Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease Progression × enzastaurin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Neoplasms 1 Lung Neoplasms 1 Glioma 1 Disease Progression 1 Brain Neoplasms 1

Interventions

umbralisib 1 ublituximab 1 marizomib 1 fludarabine phosphate 1 fludarabine 1 enzastaurin 1 carotuximab 1 brigatinib 1 binimetinib 1 axicabtagene ciloleucel 1 Zoledronic Acid 1 Vitamin D 1 Receptors, Interleukin-6 1 Irinotecan 1 Interleukin 1 Receptor Antagonist Protein 1 Cyclophosphamide 1 Calcium 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00108056 2019-12-05

Enzastaurin to Treat Recurrent Brain Tumor

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡